Yahoo! FinanceHome - Yahoo! - Help

Market Guide

[ Stock Screener | Company & Fund Index | Financial Glossary ]

Profile - Enzon, Inc. (NasdaqNM:ENZN)
As of 31-Aug-2001
Enter symbol:
symbol lookup

 
More Info: Quote | Chart | News | Profile | Research | SEC | Msgs | Insider | Options | Financials | Reports
Recent Events
Aug 21Earnings Announcement
Location
20 Kingsbridge Road
Piscataway, NJ 08854
Phone: (732) 980-4500
Fax: (732) 980-5911
Employees (last reported count): 90
Financial Links
 ·Top Institutional Holders
 ·Top Mutual Fund Holders
 ·Analyst Upgrade/Downgrade History
 ·Historical Quote Data
 ·Free Annual Report
 ·Raw SEC Filings at sec.gov
Competitors:
 ·Sector: Healthcare
 ·Industry: Biotechnology & Drugs
Company Websites
 ·Home Page
 ·Employment
 ·Products & Services
 ·Yahoo! Category

 ·Search Yahoo! for related links...

Ownership
·Insider and 5%+ Owners: 11%
·Over the last 6 months:
 · one insider sell; 3,000  shares
·Institutional: 82% (92% of float)
(380 institutions)
·Net Inst. Buying: 7.31M shares (+17.58%)
(prior quarter to latest quarter)
More From Market Guide
 ·Highlights
 ·Performance
 ·Ratio Comparisons
Business Summary
Enzon Inc. is a biopharmaceutical company that develops and commercializes enhanced therapeutics for life-threatening diseases through the application of its two proprietary platform technologies: polyethylene glycol (PEG) and single-chain antibody (SCA). The Company applies its PEG technology to improve the delivery, safety and efficacy of proteins and small molecules with known therapeutic efficacy. The Company applies its single-chain antibody technology to discover and produce antibody-like molecules that offer many of the therapeutic benefits of monoclonal antibodies, while addressing some of their limitations.
More from Market Guide: Expanded Business Description

Financial Summary
Enzon, Inc. is a biopharmaceutical company that develops, manufactures and markets enhanced therapeutics for life-threatening diseases through the application of its proprietary technologies. For the nine months ended 3/31/01, revenues rose 70% to $21.1 million. Net income applicable to Common totaled $8.2 million vs. a loss of $5.3 million. Results reflect increased ONCASPAR sales and royalties earned on sales of PEG-INTRON, and the absence of an inventory write-off.

Recent Earnings Announcement
For the 3 months ended 06/30/2001, revenues were 10,463; after tax earnings were 3,308. (Preliminary; reported in thousands of dollars.)

More from Market Guide: Significant Developments

Officers[Insider Trade Data]
FY2000 Pay

Randy Thurman, 51
Chairman
--  
Arthur Higgins, 45
Pres, CEO
--  
Kenneth Zuerblis, 41
CFO, VP-Fin., Sec.
$267K
Norman Hardman, Ph.D.
Sr. VP of Technology
--  
Dollar amounts are as of 30-June-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc..
More from Market Guide on Officers & Directors:
Expanded List, Bios, Compensation, Options
Statistics at a Glance -- NasdaqNM:ENZNAs of 31-Aug-2001
Price and Volume
52-Week Low
on 22-Mar-2001
$33.125
Recent Price$63.84 
52-Week High
on 7-Nov-2000
$84.125
Beta1.27 
Daily Volume (3-month avg)1.53M
Daily Volume (10-day avg)915.0K
Stock Performance
[one-year price graph]
big chart [1d | 5d | 3m | 6m | 1y | 2y | 5y | max]
52-Week Change+4.7%
52-Week Change
relative to S&P500
+40.4%
Share-Related Items
Market Capitalization$2.67B
Shares Outstanding41.9M
Float37.3M
Dividends & Splits
Annual Dividendnone 
Last Splitnone 
Per-Share Data
Book Value (mrq*)$3.23 
Earnings (ttm)$0.27 
Earnings (mrq)$0.08 
Sales (ttm)$0.73 
Cash (mrq*)$1.94 
Valuation Ratios
Price/Book (mrq*)19.79 
Price/Earnings (ttm)238.21 
Price/Sales (ttm)87.00 
Income Statements
Sales (ttm)$31.6M
EBITDA (ttm*)-$2.00M
Income available to common (ttm)$11.5M
Profitability
Profit Margin (ttm)36.5%
Operating Margin (ttm)-7.1%
Fiscal Year
Fiscal Year EndsJune 30
Most recent quarter
(fully updated)
31-Mar-2001
Most recent quarter
(flash earnings)
30-June-2001
Management Effectiveness
Return on Assets (ttm)8.46%
Return on Equity (ttm)9.08%
Financial Strength
Current Ratio (mrq*)12.82 
Debt/Equity (mrq*)0 
Total Cash (mrq)$0 
Short Interest
As of 8-Aug-2001
Shares Short4.65M
Percent of Float12.5%
Shares Short
(Prior Month)
4.84M
Short Ratio3.59 
Daily Volume1.30M
See Profile Help for a description of each item above;   K = thousands;   M = millions;   B = billions;   mrq = most-recent quarter;   ttm = trailing twelve months;   (as of 30-June-2001, except mrq*/ttm* items as of 31-Mar-2001)

Market Guide offers more in-depth Company Research, Stock Screening, and Hottest Stocks and Industries on over 10,000 U.S. Equities.


Copyright © 2001 Yahoo! Inc. All Rights Reserved. Privacy Policy - Terms of Service
Company information Copyright Market Guide. Historical chart data and daily updates provided by Commodity Systems, Inc. (CSI). Event data provided by CCBN. Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Market Guide, CSI, etc.) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.